ASSESSMENT OF CARDIAC FUNCTIONS IN EGYPTIAN CHRONIC HEPATITIS C PATIENTS BEFORE AND AFTER TREATMENT WITH DIRECTLY ACTING ANTIVIRALS

INTERLEUKIN 28B GENE POLYMORPHISMS AS A PREDICTOR OF TREATMENT RESPONSE IN EGYPTIANS WITH CHRONIC HEPATITIS C.

Biochemical evaluation of the combination of Pegylated IFN-α2b and Ribavarin therapy of Egyptian patients suffering from Hepatitis C Virus

Prevalence of thyroid dysfunction in Egyptian chronic hepatitis C patients treated with Pegylated interferon and Ribavirin

Direct antiviral agents related cardiac complications in HCV treated patients in Minia governorate

Cardiac Status in Hepatitis B Virus and Hepatocellular Carcinoma in Egyptian Adolescents

Pegylated Interferon, Ribavirin, and Sofosbuvir Combination versus Pegylated Interferon, Ribavirin in the Management of Chronic Hepatitis C Egyptian Patients

SAFETY AND EFFICACY OF DIRECTLY ACTING ANTIVIRAL DRUGS IN TREATMENT OF CHRONIC HCV EGYPTIAN PATIENTS

CARDIOVASCULAR EFFECTS OF ORAL ANTIVIRAL TREATMENT FOR NON-CARDIAC HCV PATIENTS

INTERLEUKIN-6 (-597G/A) POLYMORPHISM IN EGYPTIAN HEPATITIS C-VIRUS INFECTED PATIENTS